Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical implications

Overview of attention for article published in Clinical Cancer Research, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet

twitter: 113 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 13 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 185 X posts from 113 X users, with an upper bound of 894,277 followers.

@BowTiedBiotech har mange gode poster. Anbefaler å følge. Her en artikkel om targets i medisinen som finnes i nesten alle krefttyper. Precision medicine er å direkte angripe kjente mutasjoner i kreften, noe @HellandAslaug jobber med i IMPRESS. https:/

29 Oct 2023

Reply Repost Favourite

RT @BowTiedBiotech: 🎯Pan-tumor agents - this is the way. #oncology 5 Approved to date: 1. BRAFV600E 2. RET fusions 3. NTRK fusions 4. H…

25 Oct 2023

Reply Repost Favourite

RT @VivekSubbiah: Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications @CCR_AACR @OncoAlert https://t.co/…

22 Aug 2023

Reply Repost Favourite

RT @VivekSubbiah: Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications @CCR_AACR @OncoAlert https://t.co/…

22 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 181 additional X posts.